- Supported exchanges /
- SHE /
- 301211.SHE
Hubei Biocause Heilen Pharmaceutical Co. Ltd. (301211 SHE) stock market data APIs
Hubei Biocause Heilen Pharmaceutical Co., Ltd. engages in the pharmaceutical, chemical, and new energy fuel businesses in China and internationally. The company provides APIs and intermediates, and formulations; and dimethyl ether gas and a-chloropropionyl chloride chemical products. It is also involved in the contract research, manufacture, and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc. The company was founded in 1995 and is based in Jingmen, China.
Hubei Biocause Heilen Pharmaceutical Co. Ltd. Financial Data Overview
| 19.58 | |
| 19.22 | |
| - | |
| 19.75 | |
| 19.18 | |
| 13.63-25.77 | |
| 5 524 M | |
| 51.8378 | |
| 288 M | |
| 455 M | |
| 0.0214 | |
| 0.025 | |
| 0.981 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Hubei Biocause Heilen Pharmaceutical Co. Ltd. Fundamental Data is available in our Financial Data APIs
- Net Revenue 455 M
- EBITDA 57 504 K
- Earnings Per Share 0.37
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Hubei Biocause Heilen Pharmaceutical Co. Ltd. Earnings via APIs
- Latest Release 2024-09-30
- EPS/Forecast NaN
Get Hubei Biocause Heilen Pharmaceutical Co. Ltd. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
